These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7282169

  • 1. [Flow properties of blood in women on oral contraceptives (author's transl)].
    Heilmann L, Tauber PF, Siekmann U, Ludwig H.
    Zentralbl Gynakol; 1981; 103(12):678-86. PubMed ID: 7282169
    [Abstract] [Full Text] [Related]

  • 2. Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
    Ishak R, Loh Chooi Khim.
    Malays J Reprod Health; 1991 Jun; 9(1):5-8. PubMed ID: 12317443
    [Abstract] [Full Text] [Related]

  • 3. [Study of oral contraceptives action on blood folate levels (author's transl)].
    Karlin R, Bourgeay M.
    Pathol Biol (Paris); 1976 Apr; 24(4):251-5. PubMed ID: 778757
    [Abstract] [Full Text] [Related]

  • 4. Interrelationship between oral contraceptives and some parameters of the coagulative-fibrinolytic function (author's transl).
    Chieffi O, Brogioni M, Saltarelli O, Pecchioli S, Benardi M.
    Patol Clin Ostet Ginecol; 1981 Apr; 9(2):164-72. PubMed ID: 12278647
    [Abstract] [Full Text] [Related]

  • 5. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
    Hedlin AM.
    Thromb Diath Haemorrh; 1975 Apr 30; 33(2):370-8. PubMed ID: 1138426
    [Abstract] [Full Text] [Related]

  • 6. 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives.
    El Bouhmadi A, Laffargue F, Raspal N, Brun JF.
    Clin Hemorheol Microcirc; 2000 Apr 30; 22(2):99-106. PubMed ID: 10831061
    [Abstract] [Full Text] [Related]

  • 7. [Age and whole blood viscoelasticity. A risk factor study].
    Oder W, Kollegger H, Baumgartner C, Zeiler K, Oder B, Deecke L.
    Acta Med Austriaca; 1991 Apr 30; 18 Suppl 1():71-4. PubMed ID: 1950394
    [Abstract] [Full Text] [Related]

  • 8. [Effects of hormonal contraceptives on parameters of lipid metabolism (author's transl)].
    Carol W, Klinger G.
    Zentralbl Gynakol; 1980 Apr 30; 102(22):1273-82. PubMed ID: 6164181
    [Abstract] [Full Text] [Related]

  • 9. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.
    Thromb Haemost; 1996 Nov 30; 76(5):729-34. PubMed ID: 8950781
    [Abstract] [Full Text] [Related]

  • 10. Altered haemorheology in oral-contraceptive users.
    Buchan PC, Macdonald HN.
    Br Med J; 1980 Apr 05; 280(6219):978-9. PubMed ID: 7417766
    [Abstract] [Full Text] [Related]

  • 11. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA, Bonnar J.
    Thromb Haemost; 1994 Dec 05; 72(6):926-30. PubMed ID: 7740465
    [Abstract] [Full Text] [Related]

  • 12. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep 05; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 13. Increased blood viscosity in young women using oral contraceptives.
    Lowe GD, Drummond MM, Forbes CD, Barbenel JC.
    Am J Obstet Gynecol; 1980 Aug 01; 137(7):840-2. PubMed ID: 6967698
    [Abstract] [Full Text] [Related]

  • 14. [Systemic changes during the use of hormonal contraceptives].
    Manuilova IA, Trutko NS, Dubnitskaia LV, Kuramshina AKh.
    Akush Ginekol (Mosk); 1983 Nov 01; (11):14-7. PubMed ID: 6666789
    [Abstract] [Full Text] [Related]

  • 15. [Hypertension due to hormonal contraceptives and estrogens (author's transl)].
    Oelkers W.
    MMW Munch Med Wochenschr; 1978 Mar 31; 120(13):439-44. PubMed ID: 306034
    [Abstract] [Full Text] [Related]

  • 16. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Mar 31; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 17. [Impact of synthetic sexual steroids on blood volume (author's transl)].
    Klinger G, Stoll W, Zinner G, Krause G, Carol W.
    Zentralbl Gynakol; 1982 Mar 31; 104(6):343-8. PubMed ID: 7046293
    [Abstract] [Full Text] [Related]

  • 18. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 31; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 19. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Thromb Haemost; 2002 Feb 31; 87(2):199-205. PubMed ID: 11859850
    [Abstract] [Full Text] [Related]

  • 20. Oestroprogestogen interference on some haematochemical parameters: glycaemia, lipid metabolism and hepatic functionality (author's transl).
    Chieffi O, Brogioni M, Saltarelli O, Pecchioli S, Benardi M.
    Patol Clin Ostet Ginecol; 1981 Feb 31; 9(1):7-17. PubMed ID: 12278646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.